Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

Browse trials for

• Cataract 1,701
• Inflammation 3,439

Keywords

• Cataract Extraction
• Anti-Inflammatory Agents, Non-Steroidal

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's enrollment of 522 is above the median of 80 across 1,155 interventional studies indexed under Cataract.

Lead sponsor

Bausch & Lomb Incorporated is the lead sponsor of 219 studies on the registry; 7 are open to participants now.

Of its 49 completed or terminated interventional studies of FDA-regulated products, 41 (84%) have results posted.

Study arms

• Experimental
  1-bromfenac ophthalmic solution

  sterile ophthalmic solution

  Drug: bromfenac ophthalmic solution

• Placebo comparator
  2-placebo comparator

  sterile ophthalmic solution

  Drug: placebo comparator

Interventions

• Drugbromfenac ophthalmic solution
• Drugplacebo comparator

Primary outcomes

1. Reduction of ocular inflammation

Secondary outcomes

1. Secondary efficacy outcome for ocular pain will be the proportion of treated subjects that are pain free